July 29th, 2010 Dendreon’s sipuleucel-T data from the IMPACT trial shows no surprises
Yesterday was a travel day but thanks to gippy wifi and a packed day, I didn't have the opportunity to post about some interesting articles on prostate cancer published in the NEJM, which I read and digested on the train up to Boston.
